Solid-State catheterization of chlordiazepoxide polymorphs

Journal of Pharmaceutical Sciences

Volumn 87, Issue 5, 1998, Pages 655-662

  Singh, Dilraj ^a,b   Marshall, Peter V ^c   Shields, Len ^a   York, Peter ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BUTANOL; CHLORDIAZEPOXIDE; METHANOL; PROPANOL; TOLUENE;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STRUCTURE; INFRARED SPECTROSCOPY; PREFORMULATION; SOLID STATE; STRUCTURE ANALYSIS; X RAY DIFFRACTION; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TEMPERATURE; THERMOGRAVIMETRY;

CALORIMETRY, DIFFERENTIAL SCANNING; CHLORDIAZEPOXIDE; CRYSTALLIZATION; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TEMPERATURE; THERMOGRAVIMETRY; X-RAY DIFFRACTION;

EID: 0032063437     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js960385c     Document Type: Article

References (24)

1. York, P. Int. J. Pharm. 1983, 14, 1-28.
2. Haleblian, J.; McCrone, W. J. Pharm. Sci. 1969, 58, 911-929.
3. Doherty, C.; York, P. Int. J. Pharm. 1988, 47, 141-155.
4. Moustafa, M. A.; Ebian, A. R.; Khalil, S. A.; Motawi, M. M. J. Pharm. Pharmac. 1971, 23, 868-874.
5. Pikal, M. J.; Lukes, A. L.; Lang, J. E.; Gaines, K. J. Pharm. Sci. 1978, 67 (6), 767-773.
6. Corrigan O. I.; Sabra, K.; Holohan, E. M. Proc. Br. Pharm. Technol. Conf. 1982, 156-177.
7. Ibrahim, H. G.; Pisano, F.: Bruno, A.; J. Pharm. Sci. 1977, 66 (5), 671-673.
8. Lefebvre, C.; Hermann, A. M. G.; Draguet-Brughmans, M.; Bouche, R.; Guyot, J. C. Drug Dev. Ind. Pharm. 1986, 12 (11-13), 1913-1927.
9. Aguiar, A. J.; Krc, J.; Kinkel, A. W.; Samyn, J. C. J. Pharm. Sci. 1967, 56 (7), 847-853.
10. Miyazaki, S.; Arita, T.; Hori, R.; Ito, K. Chem. Pharm Bull. 1974, 22 (3), 638-642.
11. Jozwiakowski, M. J.; Williams, S. O.; Hathaway, R. D. Int. J. Pharm. 1993, 91, 195-207.
12. Summers, M. P.; Enever, R. P.; Carless, J. E. J. Pharm. Pharmac. 1976, 28, 89-99.
13. Summers, M. P.; Enever, R. P.; Carless, J. E. J. Pharm. Sci. 1977, 66 (8), 1172-1175.
14. Borka, L.; Haleblian, J. K. Acta Pharm Jugosl. 1990, 40, 71-94.
15. Bortoletti, B.; Francesconi, G.; Perlotto, T.; Vignolo, M. Farmaco (Pavia), Ed. Prat. 1966, 34, 22.
16. Simmons, D. L.; Ranz, R. J.; Picotte, P.; Szabolcs S. Can. J. Pharm. Sci. 1970, 5, 49.
17. Waldmann, H. Can. J. Pharm. Sci. 1971, 6 (3), 76-77.
18. Sternbach L. H.; Reeder, E. J. Org. Chem. 1961, 26, 1111-1118.
19. 2 Molecular Modeling Program, MSI, Cambridge, UK.
20. Watkin, D. J.; Prout, C. K.; Carruthers, J. R.; Betteridge, P. W. CRYSTALS; Chemical Crystallography Laboratory, University of Oxford: Oxford, 1992; Issue 10.
21. Byrn, S. R. Solid-State Chemistry of Drugs; Academic Press: New York, 1982.
22. Byrn S. R.; Pfeiffer, R.; Ganey, M.; Hoiberg, C.; Poochikian, G. Pharm. Res. 1995, 12 (7), 945-954.
23. British Pharmacopoeia; Her Majesty's Stationery Office: London, England, 1988; Vol. I, pp 121-122.
24. Bertolasi, V.; Sacerdoti, M.; Gill, G.; Borea, P. A. Acta Crystallogr. 1982, B38, 1768-1772.